Orgalutran

Orgalutran

ganirelix

Manufacturer:

Organon

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Ganirelix
Indications/Uses
In combination w/ recombinant FSH for prevention of premature LH surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
Dosage/Direction for Use
0.25 mg SC once daily starting on day 6 of FSH administration. COH w/ FSH May start at day 2 or 3 of menstruation. High responders Early LH rise may be prevented by starting treatment on day 5.
Contraindications
Hypersensitivity to ganirelix, dry natural rubber/latex, gonadotrophin-releasing hormone (GnRH) or any other GnRH analogue. Moderate or severe renal or hepatic impairment. Pregnancy & lactation.
Special Precautions
Discontinue use if hypersensitivity reaction is suspected. Not to be used in women w/ severe allergic conditions. May cause allergic reactions due to dry natural rubber/latex. Women <50 kg or >90 kg. Not to be used during pregnancy & lactation.
Adverse Reactions
Local inj site reaction; headache; nausea; pelvic pain, abdominal distension, ovarian hyperstimulation syndrome, ectopic pregnancy, spontaneous abortion.
MIMS Class
Trophic Hormones & Related Synthetic Drugs
ATC Classification
H01CC01 - ganirelix ; Belongs to the class of anti-gonadotropin-releasing hormones. Used in hypothalamic hormone preparations.
Presentation/Packing
Form
Orgalutran soln for inj/infusion 0.25 mg/0.5 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in